Key Takeaways COO grew EPS 14% and expanded operating margin to 24.9% despite macro challenges. Strong gains for COO's MyDay lenses and surgical devices offset weaker fertility and Asia demand. Inventory destocking and tariff risks may pressure COO's revenues and EPS into in fiscal 2026. The Cooper Companies, Inc.’s (COO) strategic investments in innovation and its diversified product base support long-term growth. However, near-term macro and inventory challenges, particularly in fertility and global con ...

Key Takeaways PLTR's U.S. commercial revenues jumped 71% year over year, hitting a $1B annual run rate for the first time. Total contract value in U.S. commercial soared 239%, with $1M deals more than doubling year over year. AIP bootcamps accelerate adoption, enabling clients to deploy production-grade AI with faster time-to-value.Palantir Technologies (PLTR) , a pioneer in big data and artificial intelligence, is experiencing a sharp increase in enterprise momentum, driven by the rapid growth of its Art ...

BTCS Secures MetaMask Order Flow and Anticipates All-Time Record Revenue in Q2July 02, 2025 9:25 AM EDT | Source: BTCS Inc.Silver Spring, Maryland--(Newsfile Corp. - July 2, 2025) - BTCS Inc. (NASDAQ: BTCS) ("BTCS" or the "Company"), a blockchain technology-focused company, short for Blockchain Technology Consensus Solutions, today announced a significant development in its Ethereum network operations. BTCS's block builder surpassed 2.7% market share of all Ethereum network transactions during ...

Microsoft Corporation (NASDAQ: MSFT ) (TSX: MSFT:CA ) is one of the tech giants I’ve held for over a decade, as I believe in its long-term potential. Back in mid-April, I published my “ Strong Buy” thesisRick is a Wall Street Journal best-selling author with over 20 years of experience trading stocks and options. The most authoritative publications, including Good Morning America, Washington Post, Yahoo Finance, MSN, Business Insider, NBC, FOX, CBS, and ABC News, cover his work. His passion is business, and ...

LOS ANGELES, July 2, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Sarepta Therapeutics, Inc. ("Sarepta" or "the Company") (NASDAQ: SRPT) for violations of the federal securities laws.Shareholders who purchased the Company's securities between June 22, 2023 and June 24, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before August 25, 2025.CASE DETAILS:  The complaint alleges that the Company made false and misleading statements to the ma ...

All three Stocks are set for a big second half.Stocks are at all-time highs, but not all stocks. To be successful in investing, we want to buy high-quality stocks and low valuations. In today's video, we will be looking at three stocks that look cheap and primed for a bounce. One of those stocks is ASML Holding (ASML -1.43%), which is yet another way to play artificial intelligence (AI).Watch this short video to learn more, consider subscribing to the channel, and check out the special offer in the link bel ...

Key Takeaways Alcon's Vision Care unit grew 3% in Q1 2025, driven by contact lens innovation and pricing gains. Alcon might face $80M in added costs from tariffs and pressure from rivals in the competitive eye care space. New launches like SYSTANE PRO PF and Voyager DSLT support ALC's growth and R&D push. Alcon’s (ALC) Vision Care business continues to gain from its diverse portfolio of contact lenses and ocular health products. Additionally, the introduction of new products is poised to help it grow in t ...

SHENZHEN, China, July 2, 2025 /PRNewswire/ -- Addentax Group Corp. (Nasdaq: ATXG) (the "Company") today announced that it has entered into a non-binding term sheet with a substantial and independent Bitcoin holder to acquire up to 12,000 Bitcoins, significantly increasing the potential acquisition size from the originally discussed 8,000 BTC as disclosed in the Company's May 15, 2025 press release. Based on prevailing market prices, the proposed acquisition represents an aggregate market value of approximat ...

公司业绩表现 - 2025年第一季度总营收同比增长754% 其中基因组学业务增长89% 数据与服务业务增长43% [1] - 基因组学业务增长受益于肿瘤检测量增长20% 以及收购Ambry Genetics带来的遗传检测收入6350万美元(该业务量增长23%) [2] - 数据与服务业务增长主要来自数据授权业务Insights 58%的提升 去年与诺华、默克EMD、武田等公司达成合作 [2] 业务发展动态 - 与阿斯利康(AZN)和Pathos签署2亿美元数据与建模许可协议 共同构建全球最大基础模型 [3] - 即将推出新型液体活检检测xM(用于治疗反应监测) 计划未来几个月进行临床发布 [3] - 首款全基因组测序(WGS)检测Xh预计明年投入临床使用 [3] 竞争对手表现 - Exact Sciences(EXAS)2025年Q1营收增长109% 主要驱动力为筛查业务(Cologuard产品) 精准肿瘤业务增长4% [4] - Exelixis(EXEL)同期营收增长306% 主要来自Cabozantinib系列药物成功 特别是CABOMETYX在美国上市 [5] 股价与估值 - 过去一年股价上涨791% 远超行业399%和标普500指数13%的涨幅 [6] - 当前12个月前瞻市销率(P/S)为785倍 高于行业平均591倍 [7] 盈利预测 - 2025年6月/9月/12月及2026年全年每股收益预测分别为-023/-018/-069/-025美元 近60天预测值有所下调 [12]

数据中心需求增长 - 公司受益于宾夕法尼亚州和肯塔基州数据中心需求增长，这些设施需要大量电力 [1] - 美国数据中心市场规模预计到2030年将达到3088.3亿美元 [1] - 人工智能工作负载增加推动数据中心市场快速扩张 [1] 公司负载增长与资本投资 - 潜在数据中心需求达11吉瓦（GW），高于之前的9吉瓦，输电资本投资预计为7-8.5亿美元 [2] - 宾夕法尼亚州2026-2034年数据中心需求增至50吉瓦 [2] - 肯塔基州路易斯维尔宣布首个400兆瓦（MW）超大规模数据中心园区 [3] - 2025-2028年计划资本投资200亿美元用于电网现代化 [3] - 2025年和2026年资本投资预计分别为43亿美元和52亿美元 [3] 公司战略定位 - 通过电网现代化、增强输配电基础设施以及与数据中心运营商合作，公司战略性地定位以抓住数据中心市场增长机会 [4] - 公司旨在可靠高效地满足需求，确保新收入来源并增强长期增长前景 [4] 其他受益的公用事业公司 - NRG能源与Menlo Equities和PowLan签署意向书，目标初始阶段零售供应400兆瓦，未来可能扩展至6.5吉瓦 [5] - Dominion能源数据中心容量近40吉瓦，其中约10吉瓦已签订电力服务协议 [6] 公司股价与财务表现 - 过去一年公司股价上涨23.4%，高于行业18.2%的涨幅 [7] - 2025年和2026年每股收益（EPS）共识预期分别增长7.69%和7.97% [10] - 当前季度（2025年6月）EPS共识预期为0.39美元，同比增长2.63% [11] - 下一季度（2025年9月）EPS共识预期为0.46美元，同比增长9.52% [11] 公司估值 - 公司12个月前瞻市盈率为17.96倍，高于行业平均14.63倍 [12]